The angiotensin-converting enzyme inhibitor captopril has been found to reduce circulating and tissue IFN-α levels, along with decreased inflammation of peripheral and central nervous system in lupus-prone mice [57]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.